February 28, 2024 BY Elizabeth Anderson
Viking Therapeutics’ weight loss drug boosts its share price
Companies such as Novo Nordisk (NVO) and Eli Lilly and Company (LLY) saw their respective share prices soar after successes with drugs such as Ozempic, Wegovy, and Mounjaro. This spurred smaller organisations, such as Viking, to test the anti-obesity market. Based on CNBC data, the obesity drug sector could total a value of roughly $100bn…
Read more